Prosecution Insights
Last updated: April 19, 2026
Application No. 19/114,057

FLUID RESPONSIVENESS USING ULTRASOUND DATA

Non-Final OA §101§112
Filed
Mar 21, 2025
Examiner
NGUYEN, HIEN NGOC
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Koninklijke Philips N V
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
4y 2m
To Grant
92%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allow Rate
403 granted / 767 resolved
-17.5% vs TC avg
Strong +40% interview lift
Without
With
+39.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
62 currently pending
Career history
829
Total Applications
across all art units

Statute-Specific Performance

§101
6.5%
-33.5% vs TC avg
§103
49.9%
+9.9% vs TC avg
§102
10.8%
-29.2% vs TC avg
§112
24.7%
-15.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 767 resolved cases

Office Action

§101 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-15 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a judicial exception (i.e., a law of nature, a natural phenomenon, or an abstract idea) without significantly more. Claims 1 recites a computer-implemented method (Step 1: Yes). In this case, the judicial exception relied upon by the instantly claimed invention is an abstract idea (Step 2A: Yes), and the limitation(s) that set(s) forth or describe(s) the abstract idea(s) is/are: “determining a first measure of a flow velocity of the blood in the blood vessel of the subject using the first ultrasound data”, “determining a first measure of a diameter of the blood vessel using the first ultrasound data”, “determining a second measure of the flow velocity of the blood in the blood vessel of the subject using the second ultrasound data”, “determining a second measure of the diameter of the blood vessel using the second ultrasound data” “determining a first ratio of blood velocity to blood vessel diameter, or a correlate thereof, using the first blood velocity measure and first blood vessel diameter measure”, “determining a second ratio of blood velocity to blood vessel diameter, or a correlate thereof, using the second blood velocity measure and second blood vessel diameter measure”, deriving an index of fluid responsiveness of the subject based on a comparison between the first ratio and second ratio”. The reason(s) that the limitation(s) are considered an abstract idea is because they are directed to functionally-described algorithmic processes that require performing mathematical calculations, and the Supreme Court has explicitly characterized mathematical relationships/formulas as abstract ideas (Federal Register, Vol. 79, No. 241, December 16, 2014 at 74622, column 2). The instantly claimed invention is also similar to claims already found to be directed to an abstract idea and patent ineligible. See at least the following court decisions: • SmartGene, Inc. v Advanced Biological Labs., 555 Fed. Appx. 950 (Fed. Cir. 2014), directed to systems, methods and computer program products for guiding the selection of therapeutic treatment regimens (ineligible) • TLI Communications LLC v. A. V. Automotive, LLC (Fed. Cir. May 17, 2016) directed to generalized steps for recording, administration and archiving of digital images, and classifying and storing digital images in an organized manner (ineligible) • Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015)., directed to a method of non-invasive prenatal diagnosis (ineligible) • Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709 (Fed. Cir. 2014), directed to methods of payment of intellectual property royalties by interposed sponsor over a telecommunications network (ineligible) • Digitech Image Techs., LLC v Electronics for Imaging, Inc., 758 F.3d 1344 (Fed. Cir. 2014), drawn to device profiles for use in a digital image processing system (ineligible) The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the additional elements when considered both individually and as an ordered combination do not amount to significantly more than the abstract idea. The claim recites the additional limitations of “receiving first ultrasound data”, “receiving second ultrasound data” and “generating a data output”. The additional elements are recited at a high level of generality and are recited as performing generic computer functions routinely used in computer applications. Generic computer components recited as performing generic computer functions that are well-understood, routine and conventional activities amount to no more than implementing the abstract idea with a computerized system. The computer just receives and generate data. Thus, taken alone, these additional elements do not amount to significantly more than the above-identified judicial exception (the abstract idea). Looking at the limitations as an ordered combination adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. Receiving and generate data is well-known in the computer field. For prong 1 of Step 2A the claim is an abstract idea as stated above. For prong 2 of Step 2A, the claims do not integrate into practical application because the claims do not claim any particular medical treatment or condition. It is merely received and generate data using a computer. With regards to the instantly rejected dependent claim(s), these claims when analyzed as a whole are also held to be patent ineligible under 35 U.S.C. 101 because the additional recited limitation(s) fail(s) to establish that the claim(s) is/are not directed to a judicial exception and/or do not add significantly more to the judicial exception. Therefore, the claim(s) is/are not patent eligible. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. For example, claims 2-15 are merely claiming using mathematical calculation, type of data and how the data are obtain. The dependent claims do not claim any particular medical treatment or condition to be considered practical application. Thus, claims 1-15 as a whole do not amount to significantly more than the exception itself (Step 2B: No). Applicant is reminded that additional steps/elements may be enough to qualify as “significantly more” if they meaningfully limit the judicial exception, improve the technology or technical field, improve the functioning of a computer itself, or add a specific limitation other than what is well-understood, routine, conventional activity in the field or unconventional steps that confine the claim to a particular useful application. For additional guidance, applicant is directed generally to MPEP 2106 and to the USPTO's Guidance on Subject Matter Eligibility (October 2019 Update). This information can be found at: http://www.uspto.gov/patent/laws-and-regulations/examination-policy/2014-interim-guidance-subject-matter-eligibility-0. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Limitation “or a correlate thereof” in claim 1 is unclear. It is unclear because there is no boundary define for “or a correlate thereof”. What does “or a correlate thereof” mean? What does applicant imply for “or a correlate thereof”? Does “a correlate thereof” mean blood velocity multiply by blood vessel diameter? Does “a correlate thereof” mean blood velocity subtract blood vessel diameter? It is unclear what applicant mean by “or a correlate thereof”. Limitation “deriving an index of fluid responsiveness of the subject based on a comparison between the first ratio and second ratio” in claim 1 is unclear. What does applicant mean by comparison. There is no boundary define for comparison and index fluid responsiveness. Does applicant compare by having first ratio subtract second ratio? Comparison can be many types of mathematical operations. Is the index fluid responsiveness a number that is a different between the first and second ratio? No art rejection The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 20210378529; US 11109831; US 10661009; US 20170202536; US 20160029995; CN 202478392 and JP 2007007200. These are the closest prior art. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HIEN NGOC NGUYEN whose telephone number is (571)270-7031. The examiner can normally be reached Monday-Thursday 8:30am-6:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Kozak can be reached at 571-270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HIEN N NGUYEN/ Primary Examiner Art Unit 3797
Read full office action

Prosecution Timeline

Mar 21, 2025
Application Filed
Mar 03, 2026
Non-Final Rejection — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12569160
SYSTEM AND METHOD FOR DETECTING POSITION OF LONG MEDICAL DEVICE
2y 5m to grant Granted Mar 10, 2026
Patent 12564736
NON-INVASIVE ULTRASOUND NEUROMODULATION FOR VISION RESTORATION FROM RETINAL DISEASES
2y 5m to grant Granted Mar 03, 2026
Patent 12558574
METHOD AND SYSTEM FOR PARAMETERISING A HIGH-INTENSITY FOCUSED ULTRASOUND TREATMENT DEVICE
2y 5m to grant Granted Feb 24, 2026
Patent 12551729
MULTI-BEAM NEUROMODULATION TECHNIQUES
2y 5m to grant Granted Feb 17, 2026
Patent 12543959
DEVICE, SYSTEM AND METHOD FOR MONITORING OF PERIPHERAL ARTERIAL PERFUSION OF A SUBJECT
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
92%
With Interview (+39.8%)
4y 2m
Median Time to Grant
Low
PTA Risk
Based on 767 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month